1. Home
  2. CDNA vs ARRY Comparison

CDNA vs ARRY Comparison

Compare CDNA & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$21.55

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Logo Array Technologies Inc.

ARRY

Array Technologies Inc.

HOLD

Current Price

$8.19

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
ARRY
Founded
1998
1989
Country
United States
United States
Employees
765
N/A
Industry
Medical Specialities
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.2B
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
CDNA
ARRY
Price
$21.55
$8.19
Analyst Decision
Buy
Buy
Analyst Count
6
19
Target Price
$28.00
$10.21
AVG Volume (30 Days)
744.0K
4.9M
Earning Date
04-28-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
62.56
EPS
0.05
N/A
Revenue
$48,324,000.00
$1,284,141,000.00
Revenue This Year
$16.01
$15.72
Revenue Next Year
$11.31
$8.08
P/E Ratio
$430.00
N/A
Revenue Growth
18.93
40.22
52 Week Low
$10.96
$5.39
52 Week High
$23.24
$12.23

Technical Indicators

Market Signals
Indicator
CDNA
ARRY
Relative Strength Index (RSI) 58.59 54.29
Support Level $16.63 $8.18
Resistance Level $23.19 $9.75
Average True Range (ATR) 1.46 0.51
MACD -0.04 0.07
Stochastic Oscillator 66.57 47.51

Price Performance

Historical Comparison
CDNA
ARRY

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes, and electronic controllers referred to as a single-axis tracker that moves solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil, and the rest of the world, with the United States deriving the majority of the revenue.

Share on Social Networks: